Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Nirav Niranjankumar Vora as Chief Financial Officer of the company w.e.f. October 07, 2025.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals Limited has appointed Mr. Nirav Niranjankumar Vora as the new Chief Financial Officer of the company. The appointment takes effect from October 07, 2025. Mr. Vora will head the finance function at the company going forward. The company has informed the stock exchange about this key managerial personnel change as required under listing regulations. No further details about his background or the outgoing CFO were mentioned in the filing.
This is a routine leadership change at the finance level and is not expected to materially impact the stock price. Shareholders should watch for any further disclosures about Mr. Vora's experience and the company's financial strategy under the new CFO.